Group A:Recombinant Adenovirus-Herpes Simplex Virus Thymidine Kinase (ADV-TK) combined with Ganciclovir

2 trials

Sponsors

Shenzhen Tiandakang Gene Engineering Co., Ltd.,, Shenzhen Tiandakang Gene Engineering Co., Ltd.

Conditions

Head and neck cancer in late-stagePrimary hepatocellular carcinoma in late stage

Phase 2

Phase II study of Recombinant Adenovirus-Herpes Simplex Virus Thymidine Kinase (ADV-TK) combined with Ganciclovir in recurrent head and neck cancer of late-stage

Active, not recruitingChiCTR-ONRC-11001232

Shenzhen Tiandakang Gene Engineering Co., Ltd.,Head and neck cancer in late-stage

Start: 2007-12-21Updated: 2017-04-18

Phase II study of Recombinant Adenovirus-Herpes Simplex Virus Thymidine Kinase (ADV-TK) combined with Ganciclovir in primary hepatocellular carcinoma

Active, not recruitingChiCTR-ONRC-11001233

Shenzhen Tiandakang Gene Engineering Co., Ltd.Primary hepatocellular carcinoma in late stage

Start: 2007-11-29Updated: 2017-04-18